{
      "ptx_code": "PTX007",
      "chem_name": "Acrylamide",
      "casrn": "79-06-1",
      "dtxsid": "DTXSID5020027",
      "smiles": "NC(=O)C=C",
      "inchikey": "HRPVXLWXLXDGHG-UHFFFAOYSA-N",
      "label": "PTX007 | Acrylamide",
      "pubchem_cid": "6579",
      "drugbank_id": "",
      "use_class": "Food and other consumption",
      "tox_class": "Neurotoxicity; Genotoxicity",
      "formula": "C3H5NO",
      "chem_name_user": "Acrylamide",
      "mw_g_mol": "71.08",
      "solubility_h2o_mol_liter": "8.98",
      "source_solubility_h2o": "COMPTOX",
      "henry_coefficient_atm_m3_mol": "2.48e-08",
      "source_henry": "COMPTOX (Opera)",
      "log_kaw_kh_rt": "5.99",
      "source_kaw": "LSER eq 1",
      "pka_acid": "15.10",
      "pka_base": "-0.40",
      "source_pka": "ACD pKa/GALAS",
      "log_kow_liter_liter": "-0.67",
      "source_kow": "Yalkowsky et al. Chemosphere 2002, 48, 487\u2013509",
      "log_dlipw_ph74_liter_liter": "-0.22",
      "source_dlipw": "LSERD, cited in Huchthausen 2023",
      "freely_dissolved_fraction": "0.94",
      "density_kg_liter": "0.97",
      "source_density": "COMPTOX",
      "boiling_point": "125.0; 192.6; 237.5",
      "source_boiling_point": "CompTox (Alfa Aesar (Chemical company; PhysPropNCCT; NIOSH)",
      "melting_point": "83.5; 84.5; 85.0; 86.0",
      "source_melting_point": "CompTox (Alfa Aesar (Chemical company; Jean-Claude Bradley Open Melting Point Dataset; Tokyo Chemical Industry (Chemical company; Tokyo Chemical Industry (Chemical company)",
      "vapor_pressure": "7.00e-03",
      "source_vapor_pressure": "CompTox (PhysPropNCCT)",
      "baseline_drerio": "274000.00",
      "baseline_dmagna": "49800.00",
      "baseline_celegans": "106179.24",
      "baseline_xlaevis": "10400.30",
      "baseline_dmelanogaster": "459928.16",
      "baseline_cells": "0.05",
      "baseline_cells_generic_micromole_liter_free_ec10": "0.04",
      "moa_drugbank": "",
      "protein_binding": "",
      "moa_t3db": "",
      "aop": [
            {
                  "AOP_id": 6,
                  "AOP_name": "Antagonist binding to PPAR\u03b1 leading to body-weight loss "
            },
            {
                  "AOP_id": 18,
                  "AOP_name": "PPAR\u03b1 activation in utero leading to impaired fertility in males "
            },
            {
                  "AOP_id": 34,
                  "AOP_name": "LXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 58,
                  "AOP_name": "NR1I3 (CAR) suppression leading to hepatic steatosis "
            },
            {
                  "AOP_id": 61,
                  "AOP_name": "NFE2L2/FXR activation leading to hepatic steatosis "
            },
            {
                  "AOP_id": 72,
                  "AOP_name": "Epigenetic modification of PPARG leading to adipogenesis "
            }
      ],
      "targets": []
}